________________________________________________________________________________________________________________________________

(C) Frank Ubags 2009Frank Ubags aims for a global reach of Scil Proteins

July 2009. Frank Ubags joins as Financial Officer Scil Proteins at Halle, Germany . He has to increase profitability fo investor BioNet Holding (formerly Engelhorn). B2Bioworld asked Mr. Ubag. He brings his own ideas with it.

 

 

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 1 page

Full Company License enquire here

Back to section

 

Editor's Note

Frank Ubags left Scil Proteins in November 2012. Founder Ulrike Fiedler stepped down as Managing Director December 4, 2013, while Henning Afflerbach and Ulrich Haupt manage the company since September.

updated December 2013

Related Editorial Articles

MerckSerono Manufacturing: We have biosimilars coming …

Sanofi: Triggering Regenerative Functions with Transplanted Cells and Small Molecules
Kurt Stoeckli, Global Head of Biological Sciences / Discovery Sanofi Aventis and Scientific Director

Stem Cells: a discovery tool and a potential therapeutic modality
Jonathan Knowles, Former Member of the Roche Executive Committee and Head of Group Research Leveraging different methods and technologies – clarifying the concept of personalised medicine

Handling Suppliers of Mass Spectrometers Delicately
Michael P. Myers, International Centre for Genetic Engineering and Biotechnology, Trieste (IT) tells how he is avoiding to get trapped by manufacturers of mass spectrometers and their strategies to fend off competitors with proprietary data formats

Electrophoresis in Proteomics
– Some Common Pitfalls and Smart Ways to Avoid Them